Biomaterials Market by Product Type (Natural, Metallic, Ceramics, Polymer), By Application (Cardiovascular, Neurological Disorder, Orthopaedics, Plastic Surgery, Dental Implants and Wound Healing, Ophthalmology, and Other Applications), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

Report Overview

Biomaterials Market size is expected to be worth around USD 540.5 Billion by 2032 from USD 155.9 Billion in 2022, growing at a CAGR of 13.6% during the forecast period from 2023 to 2032.

Biomaterials are specially produced and utilized in clinical inventions to work on the capability of harmed tissues, bones, and organs. These biomaterials are used in clinical equipment and inserted that enhance or replace standard body capabilities. Implantable biomaterials are intended to reduce the unpleasant safe response while protecting suitable ability because the body allows unknown material to expand its organic exercises. These biomaterials collaborate with natural systems for clinical targets, including treating cardiovascular, dental, muscular, and neurological sicknesses.

Development in the geriatric populace, ascend in the predominance rate of cardiovascular and muscular problems, progress in clinical innovation, and expansion in mindfulness concerning the implantable system drive the development of the biomaterials market. Also, subsidizing by the government to expand research and development exercises in the field of biomaterial-based implants and expansion in observation about the upsides of biomaterials items further drive the development of the market.

In any case, the significant expense of biomaterial inserts and similarity issues are supposed to restrict the market’s growth. Then again, the presentation of new advances, to be specific decellularized dermal lattices for uniting and introducing new items in the field of plastic surgery, wound healing, and nervous system science, are supposed to offer productive open doors for the development of the market during the estimate time frame.

Key Takeaways

• Global Biomaterials Market is expected to reach USD 540.5 Billion by 2032, with a CAGR of 13.6% from 2023 to 2032.
• Biomaterials are used to improve or replace damaged tissues, organs, and bones in clinical applications.
• Growth drivers include an aging population, increased prevalence of cardiovascular and musculoskeletal disorders, technological advancements, and government funding for research.
• High costs and compatibility issues are restraining factors in the biomaterials market.
• New technologies like decellularized dermal matrices and smart biomaterials offer growth opportunities.
• Product types include metallic, polymeric, ceramic, and natural biomaterials.
• Orthopedic applications dominate the market, driven by metallic biomaterials’ high load-bearing capacity.
• Plastic surgery and wound healing applications are expected to grow significantly due to aesthetic procedures and biomaterial use.
• Stringent clinical and regulatory processes pose challenges for biomaterial-based medical devices.
• North America holds the largest share of the biomaterials market at 35.5%.
• Emerging economies like Brazil, India, South Africa, and China are driving market growth through healthcare infrastructure development.
• Asia-Pacific offers opportunities for biomaterial companies due to growing medical infrastructure and demand for biomaterials.

Product Type Analysis

Based on product type biomaterials market is segmented into metallic, polymeric, ceramic, and natural biomaterials. The metallic fragment is mainly utilized in orthopedic, dental, cardiovascular, joint replacements, and neurological extremely durable and bioresorbable inserts, which drives the development of the section. Ceramic biomaterials divide into calcium phosphate, aluminum oxide, calcium sulfate, carbon, and glass. Natural biomaterials include hyaluronic corrosive, collagen and gelatin, fibrin, cellulose, chitin, and silk.

Metallic biomaterials are separated into treated steel, titanium, and titanium compounds, cobalt-chrome blends, gold, and silver. Polymeric biomaterials have a high degree of communication with the body, which can cause distance and consume essential supplements and water from the blood. Because of such limitations, the market players must be careful before driving resources into this area. Besides, metal biomaterials may encounter erosion in light of substances and natural responses inside the body, like catalysts and acids, or because of metal particle toxicity.

Some biomaterials might hinder bone growth or relaxation, forever eliminated after some time. In any case, the product development interest for smart biomaterials that produce and move bioelectric signals like local tissues for exact physiological capabilities are supposed to speed up the market development in the estimated period.

Application Analysis

By Application analysis, the biomaterials market is segmented into cardiovascular, neurological disorders, orthopedics, plastic surgery, dental implants and wound healing, ophthalmology, and other applications. In 2022, the orthopedic application category accounted for the largest revenue share in the overall biomaterials market. As a result of their high load-bearing capability, metallic biomaterials are increasingly being used, which is one of the key drivers driving the segment’s rise. In addition, substantial innovations and ongoing investments by market players in the advancement of orthopedic implants are projected to fuel market expansion in the upcoming years. For instance, the Xiphos-ZF spinal interbody device developed by DiFusion Inc. and based on Zfuze, a distinct biomaterial consisting of titanium and poly-ether-ether-ketone, received FDA approval in November 2019.

Additionally, it is predicted that the field of plastic surgery will expand significantly over the course of the projection period due to the rise in aesthetic operations and the major use of biomaterials in these treatments. Nearly 4.3 million cosmetic treatments were carried out in the United States in 2018, according to the International Society of Aesthetic Plastic Surgery Report 2019, which favorably impacts the segment’s growth.

Key Market Segments

Based on Product Type

• Metallic
• Natural
• Ceramics
• Polymers

By Application

• Cardiovascular
• Neurological Disorder
• Orthopedics
• Plastic Surgery
• Dental Implants
• Wound Healing
• Ophthalmology
• Other Applications

Driving Factor

Growing Demand for Biomaterials in Plastic Surgery and Wound Healing Applications

Plastic surgery procedures and wound curing are noticeable application regions for biomaterial-based items. In Plastic Medical procedures, biomaterials are generally utilized in inserting, covering, and fixing light tissue wounds, consuming, and expanding openings in the human body, usually and securely. Key organizations are speculating about growing their presence and keeping an upper hand. They likewise hold techniques like arrangements, associations, and cooperation models to support their product portfolio.

Innovations and technological achievements will drive the demand for biomaterials in Plastic Surgery and wound healing applications in the coming years. Biomaterials have generally intended to match the first construction and structure of ECM and give immediate and practical help to cells, especially in helpful settings for re-developing or fixing harmed tissues. Cardiovascular breakdown is one of the primary sources of bleakness and mortality everywhere.

Over 5 million patients are experiencing determined cardiovascular breakdown post-myocardial localized necrosis caused by ischemic coronary illness. The sickness creates throughout some periods because of the loss of cardiomyocytes. The condition is also bothered by difficulties connected with determination, hypertension, diabetes, smoking, and fluid utilization.

Restraining Factor

Severe Clinical and Regulatory Processes

Biomaterial-based material devices are regulated in various regions, including North America, European countries, and Asia Pacific, to ensure effectiveness. It is mainly because biomaterial-based material medical devices are insertable. All new biomaterials require confirmation that they are secured and reasonable before they maintain for showcasing. The U.S. agreement process follows strict protocols set by Food and Drug Administration. And according to the FDA, biomaterials-based products are implantable peacemakers and heart valve devices with the highest developing risk of injury and illness.

Poor natural Identification on the material surface is the most widely recognized limit experienced with biomaterials, and surface covering or surface change is generally used to reduce this impediment. The main objective of biomaterial is to reproduce an in vivo situation. One of the challenges experienced while endeavouring to make cartilage bone is the production of platforms with good mechanical properties, and the repairing system is age dependent.

Opportunities

The Global Biomaterials Market is also boosted owing to growing healthcare industries in several emerging economies like Brazil, India, South Africa, and China. The rapidly growing geriatric population, high patient volumes, rising per capita incomes, and spiking awareness among people are driving the need for enhancing the healthcare industries in these nations. Fat tissue removal is an effective treatment for delicate facial abnormalities initiated by facial plastic medical procedures and injuries. Reconstruction of adipose tissue is possible by fat transplantation as well as biomaterial filling.

Biomaterials are lifeless substances that come into contact with living tissues for therapeutic purposes. This difference is from similar fat transplantation. Biomaterials give the advantages of direct access, minor damage to the contributor region, and the capacity to customize to clear requirements. Therefore, the governments in these economies are raising their investments aimed at improving infrastructure & healthcare facilities.

Owing to the high number of applications of surface disinfectant products in healthcare industries, the rising investment in this industry is expected to offer rising demand for medical implants and growth opportunities in the market.

Trends

The progress of the organized cardiovascular segment, which will consider the complications of heart tissue, is subject to biomaterials, for example, peptides cross-connected to platforms. Future cardiovascular scar substitution will find lasting success while utilizing biomaterials that encourage tissue recovery without enacting a safe framework and bringing about relocation rejection. Biomaterials are used to evaluate better approaches to advance these circumstances. They are made as structures that duplicate the nerve tissue’s extracellular matrix and promote axonal recovery when installed.

Additionally, biomaterial frameworks can be made to convey mending specialists to the harm site. The recuperating rate in youngsters is quick, while the pacemaker changes for mature individuals. Numerous materials with excellent mechanical characteristics need significant porosity, and some have shown potential in vitro bombs in vivo because of the unfortunate vascularization limit. The dental fragment is supposed to develop over the forecast period in the coming years.

Regional Analysis

Asia-Pacific offers opportunities for many companies working in the biomaterials market

North America overcame the market and represented the most significant income of 35.5% attributable to the drives incorporated by different public and confidential associations. These integrate the public science establishment and the public organization of innovation, which gives information and helps relate to biomaterials utilization in biomedical applications.

Asia-Pacific offers opportunities for vital participants working in the biomaterials market, attributable to the developing medical services foundation, rise in frequency of ophthalmic, neurological, Cardiovascular, and orthopedic Disorders rise in well-established national companies. Asia-Pacific The developing elderly population and surgical demand are expected to drive the Asian-Pacific market.

In India, the biomaterials market is continually rising. Muscular, dental, and cardiovascular biological systems overpower the Indian biomaterials industry. Expanding share market of cardiovascular and muscular, and biomaterial items are because of an expansion in muscular medical procedure, cardiovascular medical procedures, vascular grafts, and dental methods.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Emerging key players are focused on various strategic policies to develop their respective businesses in foreign markets. Several biomaterials market companies are concentrating on expanding their existing operations and R&D facilities. Furthermore, productions in the biomaterials market are developing new products and portfolio expansion strategies through investments, mergers, and acquisitions.

In addition, several key players are now focusing on marketing strategies, like Royal DSM, Invibio Ltd., Evonik Industries AG, CoorsTek Inc., Berkeley Advanced Biomaterials, Inc., CAM Bioceramics BV, and others. Market development is driven basically by variables like the expanded assets and awards by government bodies overall for the advancement of novel biomaterials, rising interest for clinical inserts, and the rising frequency of cardiovascular infections, expanding research on regenerative medication, such as spreading awareness about natural ingredients and boosting the target products’ growth.

With the presence of many local and regional players, the market for biomaterials is fragmented. Market players are subject to intense competition from top market players, particularly those with strong brand recognition and high distribution networks. To stay on top of the market, companies have gained various expansion strategies such as partnerships and product launches.

The following are some of the major players in the global biomaterials Market.

Market Key Players

• Royal DSM
• BASF SE
• Corbion N.V.
• Covestro
• Invibio Ltd.
• Carpenter Technology Corporation
• Evenki Industries AG
• Berkeley Advanced Biomaterials, Inc.
• CAM Bio Ceramics BV
• Celanese Corporation
• Other Key Players

Recent Developments

• In August 2023: BASF completed the divestiture of its nickel-based catalysts production facility in De Meern, Netherlands, to IQatalyst B.V. This transaction, valued at €13 million, included the associated infrastructure and inventories, marking a strategic portfolio adjustment within BASF’s Catalysts division.
• In June 2023: DSM completed its merger with Firmenich, creating a global leader in nutrition, health, and beauty. This merger is expected to deliver significant revenue synergies, estimated to contribute about €100 million in Adjusted EBITDA by 2024.
• In May 2023: Corbion, in collaboration with MedinCell, enabled the launch of a new FDA-approved drug delivery product to treat schizophrenia. This development utilized Corbion’s biopolymer manufacturing expertise, specifically their polyethylene glycol- (PEG) and polylactide-based (PLA) copolymers, produced in a joint venture established in 2015. This marked the first approved product using their BEPO® technology, showcasing Corbion’s capability in supporting innovative drug delivery solutions.
• In April 2023: Acquisition by Stratasys, Covestro’s additive manufacturing materials business was acquired by Stratasys, enhancing Stratasys’ leadership in the polymer additive manufacturing industry. This acquisition included research and development facilities, global development and sales teams, and a portfolio of approximately 60 additive manufacturing materials, furthering innovations in key technology categories such as stereolithography and powder bed fusion​.

Report Scope